期刊文献+

负性协同刺激分子B7-H4在非小细胞肺癌组织中的表达及其临床意义 被引量:3

Expression of negative costimulatroy molecule B7-H4 in non-small cell lung cancer tissues and its clinical significance
下载PDF
导出
摘要 目的:探讨负性协同刺激分子B7-H4在原发性非小细胞肺癌(non-small cell lung cancer,NSCLC)组织中的表达及其与NSCLC临床病理特征间的关系。方法:选取南通大学第三附属医院胸外科2008年1月至2009年4月手术切除并经病理证实的NSCLC标本52例。免疫组织化学法检测NSCLC组织中B7-H4分子的表达及CD3+T细胞浸润程度,分析B7-H4表达水平与NSCLC组织中CD3+T细胞浸润、临床病理特征间的关系。结果:52例NSCLC组织中B7-H4表达阳性率为48.08%(25/52),正常肺组织不表达或较少表达B7-H4,差异具有统计学意义(P<0.05)。B7-H4表达水平与NSCLC临床分期和淋巴结转移呈正相关(P<0.05),与CD3+T淋巴细胞浸润程度呈负相关(P<0.05),与其他临床病理参数无关(P>0.05)。结论:负性协同刺激分子B7-H4在NSCLC发病过程中可能起重要的作用,其阳性表达与NSCLC临床分期及淋巴结转移密切相关,B7-H4为NSCLC的诊断及治疗提供参考依据。 Objective: To study the expression of negative costimulatroy molecule B7-H4 in non-small cell lung cancer (NSCLC) tissues and its relationship with the clinical features of NSCLC. Methods : Fifty-two NSCLC specimens from pa- tients who were pathologically diagnosed in our hospital during January 2008 to April 2009 were included in the present study. B7-H4 expression and infiltration of CD3 +T cells in NSCLC tissues were detected by immunohistochemistry. The correlation between B7-H4 expression, CD3+ T infiltration, and the clinical features of NSCLC was studied. Results : The positive rate of B7-H4 in 52 NSCLC tissues was 48.08% (25/52) , and B7-H4 expression in normal lung tissues was negative or low ( P 〈 0.05 ). B7-H4 expression was positively correlated with the clinical tumor stages and lymph node metastasis of NSCLC ( P 〈 0.05 ), and negatively correlated with tumor infiltration of CD3+ T cells ( P 〈 0.05 ), but had no relationship with clinicopathologic parameters of NSCLC ( P 〉 0.05 ). Conclusion : Negative costimulatroy molecule B7-H4 may play important roles in the development of NSCLC. Positive expression of BT-H4 is correlated with the clinical tumor stages and lymph node metastasis of NSCLC, which provides a foundation for diagnosis and therapy of NSCLC.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2009年第6期633-636,共4页 Chinese Journal of Cancer Biotherapy
关键词 非小细胞肺癌 B7-H4 T细胞 负性协同刺激分子 non-small cell lung cancer (NSCLC) B7-H4 T cell negative costimulatroy molecule
  • 相关文献

参考文献24

  • 1张晶,谢幸,叶大风.黏附分子与肿瘤免疫逃逸[J].实用肿瘤杂志,2004,19(5):449-452. 被引量:18
  • 2刘杰,孙玉萍,汪运山,刘惠萍,张秀兰.B7-H4在乳腺癌中表达的临床意义[J].临床肿瘤学杂志,2007,12(11):830-832. 被引量:5
  • 3Sica GL, Choi IH, Zhu G, et al. B7-H4, a member of the B7 family, negatively regulates T ceil immunity [ J ]. Immunity, 2003, 18(6) : 849-861.
  • 4傅振坤,章婕,李殿俊.B7-H4与肿瘤关系的研究进展[J].国际免疫学杂志,2008,31(1):32-34. 被引量:2
  • 5孙玉萍,刘杰,崔霞,赵东,刘惠萍,汪运山.B7-H4在结直肠癌组织中表达的临床意义[J].山东大学学报(医学版),2006,44(6):590-592. 被引量:14
  • 6Tringler B, Liu W, Corral L, et al. B7-H4 overexpression in ovarian tumors [J]. Gynecol Oncol, 2006, 100( 1 ) : 44-52.
  • 7Simon I, Zhou S, Corral E, et al. B7-H4 is a novel membrane- bound protein and a eandidate serum and tissue biomarker for ovarian cancer [J]. Cancer Res, 2006, 66(3) : 1570-1575.
  • 8Miyatake T, Tringler B, Liu W, et al. BT-H4 is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration [J]. Gynecol Oncol, 2007, 106(1) : 119-127.
  • 9李文桦,刘瑞梓,杨秀利,乔滨,熊思东.肿瘤模型中B7-H4和BTLA的异常表达[J].中国癌症杂志,2005,15(4):313-316. 被引量:7
  • 10Sun Y, Wang Y, Zhao G, et al. B7-H3 and BT-H4 expression in non-small-cell lung cancer [ J ]. Lung Cancer, 2006, 53 ( 2 ) : 243-151.

二级参考文献71

  • 1王艳艳,白云,宋建勋,杨晓亚.OX40信号上调Survivin表达对CD4^+T淋巴细胞增殖存活的影响[J].免疫学杂志,2005,21(2):81-83. 被引量:3
  • 2孙玉萍,刘杰,崔霞,赵东,刘惠萍,汪运山.B7-H4在结直肠癌组织中表达的临床意义[J].山东大学学报(医学版),2006,44(6):590-592. 被引量:14
  • 3Sica GL , Choi I H , Zhu G, et al. B7-H4 , a molecule of the B7 family ,negatively regulates T cell immunity . Immunity , 2003,18 (6) :849-861.
  • 4Prasad DV ,Richards S ,Mai XM, et al. B7S1 ,a novel B7 family member that negatively regulates T cell activation. Immunity ,2003, 18 (6):863-873.
  • 5Zang X,Loke P ,KimJ, et al. B7x :a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci USA , 2003 , 100 (18) :10388-10392.
  • 6Hirotsune S , Yoshida N ,Chen A, et al. An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene. Nature ,2003 ,423(6935) :26-28.
  • 7Tringler B, Zhuo S, Pilkington G, et al. B7-H4 is highly expressed in ductal and lobular breast cancer. Clinical Cancer Res, 2005,11 (5) :1842-1848.
  • 8Sadun RE, Sachsman SM, Chen X,et al. Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy. Clin Cancer Res, 2007 , 13 ( 13 ) :4016-4025.
  • 9Salceda S, Tang T, Kmet M, et al. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res, 2005,306 ( 1 ) : 128- 141.
  • 10Tringler B, Liu W, Corral L, et al. B7-H4 overexpression in ovarian tumors. Gynecol Oncol, 2006, 100(1 ) : 44-52.

共引文献44

同被引文献20

  • 1钱运智,陈卫红,王秀兰,杨德娟,陈镜琼.接尘工人肺癌患者胸片分析[J].同济医科大学学报,1995,24(3):205-205. 被引量:4
  • 2葛蕙心,畅继武.B7-1、GPI及其拼接在肿瘤免疫治疗中的应用进展[J].山东医药,2006,46(29):78-79. 被引量:2
  • 3Shin T, Kennedy G, Gorski K, et al. Cooperative B7-1/2 (CD80/ CD86) and B7-DC costmiulation of CD+ T cells independent of the PD-1 receptor [J]. J Exp Med, 2003,198(1 ) :31-38.
  • 4Chert L. Co-inhibitory molecules of the B7-CD28 family in the con- trol of T-cell immunity [ J ]. Nature Rev Immunol, 2004,4 ( 5 ) :336-347.
  • 5Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 fam- ily, negatively regulates T cell immunity [J]. Immunity, 2003,18 (6) :849-861.
  • 6Simon I, Zhuo S, Corral L, et al. B7-h4 is a novel membrane- bound protein and a candidate serum and tissue biomarker for ovari- an cancer [J]. Cancer Res, 2006,66(3) :1570-1575.
  • 7Simon I, Katasaros L, Riqault de la Lonqrais I, et al. B7-H4 is o- ver-expressed in early stage ovarian cancer and is independent of CA125 expression [ J ]. Gynecol Oncol, 2007,106 ( 2 ) : 334-341.
  • 8Kryczek I, Wei S, Zhu G, et al. Relationship between B7-H4, reg- ulatory T ceils, and patient outcome in human ovarian carcinoma [ J ]. Cancer Res, 2007,67 ( 18 ) : 8900-8905.
  • 9Salceda S, Tang T, Kmet M, et al. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation [ J]. Exp Cell Res, 2005,6 ( 1 ) : 128-141.
  • 10Thompson RH, Zang X, Lohse CM, et al. Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with ad- vanced stage [J]. Cancer Res, 2008,68(15) :6054-6058.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部